Bromocriptine-QR may reduce CVD risk in type 2 patients independent of its effect on glycemic control.

Is the Diabetes Knowledge Test 2 (DKT2) a reliable way to show where you need to start in educating your patient for self-care?

Mr. Carlson is a 52-year-old Caucasian grocery store manager you saw last week for a new patient visit. His labs from that visit were significant for elevated random plasma glucose 166 mg/dL, A1C 7.4% and elevated lipids (TG=175 mg/dL, LDL 148 mg/dL, HDL 38 mg/dL, total cholesterol 221 mg/dL). He has returned to your clinic for a follow-up appointment. His physical exam is notable for central abdominal obesity (waist circumference 42”), left eyelid xanthelasma, BP 147/91, HR 72, RR 18, BMI 36 kg/m2, but otherwise normal. A repeat A1C test shows A1C 7.6%. Mr. Carlson smokes between 1 and 1.5 packs of cigarettes daily. After discussing the labs and your findings with Mr. Carlson, you begin collaborating on a management plan. You write prescriptions for metformin, a statin and ACE inhibitor. Mr. Carlson doesn’t think “taking medication will be too tough,” but expresses skepticism about your recommendations for a change in his diet, exercise and smoking programs because he has tried them, without success, in the past. You are concerned about Mr. Carlson’s cigarette use because cigarette smoking has been shown to have multiple physiological impacts on health. Which one of the following statements regarding smoking and type 2 diabetes is true? A. It equally affects all-cause mortality in individuals with and without diabetes. B. In individuals with diabetes, it causes more rapid progression to micro- and macroalbuminuria. C. It has not been linked to worsening glycemic control. D. The use of bupropion is contraindicated in diabetes. Follow the link to see the correct answer!

Innovation and improvement in CGMS technology has risen dramatically over the last 2 years, paving the way for the artificial pancreas.

In part 1 of this exclusive video, DIC publisher Steve Freed once again visits with Dr. George Bakris to discuss the many blood pressure guidelines and what they should be for adults and those with diabetes.

A professional society looks into how much physical activity is good for a healthy lifestyle.

What will be the impact of the new biosimilar insulins now in development?

A sedentary lifestyle may lead to type 2 diabetes and metabolic syndrome.

Empagliflozin is proving to be a strong proponent for monotherapy in patients with T2DM.

Could study of FOXO transcription factors one day lead to new therapies?